As of November 2024 Biohaven Pharmaceutical has a market cap of S$6.16 Billion. This makes Biohaven Pharmaceutical the world's 2882th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Biohaven Pharmaceutical was reported to be: